Trial at 36 Months: 37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose groups with 95% of patients off all topical IOP-lowering drops100% of evaluable patients ...

T'puram: The pre-test for India's first-ever digital census has commenced in Kerala, with Palakkad, Ernakulam and Idukki ...

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

BioCardia (BCDA) announced the first patient enrolled at Henry Ford Health in its ongoing Phase 3 CardiAMP HF II clinical trial for patients with ...

Clear Creek ISD has officially rolled out a new bus badging system that allows parents to monitor their student’s bus activity through a mobile application.

France, Germany and Spain are set to resume high-level talks on the next phase of a major fighter project after delays caused by the recent political crisis in France, three people familiar with the ...

Battie can already grab and go in transition and play a face-up option to exploit mismatches in the half-court. For example, ...

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...

The Election Commission of India (ECI) said on Tuesday that Bihar registered an overall voter turnout of 66.91 per cent, its ...

BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled at ...

In what experts are calling a breakthrough in the global fight against malaria, a new next-generation drug candidate — GanLum (ganaplacide/lumefantrine, KLU156) — has shown a 97% cure rate in Phase 3 ...